These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 35759503)

  • 1. Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.
    Abdullaev A; Abdurakhimov A; Mirakbarova Z; Ibragimova S; Tsoy V; Nuriddinov S; Dalimova D; Turdikulova S; Abdurakhmonov I
    PLoS One; 2022; 17(6):e0270314. PubMed ID: 35759503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic.
    Anwar MZ; Lodhi MS; Khan MT; Khan MI; Sharif S
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.
    Sahin E; Bozdayi G; Yigit S; Muftah H; Dizbay M; Tunccan OG; Fidan I; Caglar K
    J Med Virol; 2021 Oct; 93(10):6016-6026. PubMed ID: 34241906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.
    Sassi MB; Ferjani S; Mkada I; Arbi M; Safer M; Elmoussi A; Abid S; Souiai O; Gharbi A; Tejouri A; Gaies E; Eljabri H; Ayed S; Hechaichi A; Daghfous R; Gouider R; Khelil JB; Kharrat M; Kacem I; Alya NB; Benkahla A; Trabelsi S; Boubaker IB
    Infect Genet Evol; 2022 Aug; 102():105300. PubMed ID: 35552003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan.
    Ayubov MS; Buriev ZT; Mirzakhmedov MK; Yusupov AN; Usmanov DE; Shermatov SE; Ubaydullaeva KA; Abdurakhmonov IY
    PLoS One; 2022; 17(3):e0266417. PubMed ID: 35358277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.
    Gunadi ; Wibawa H; Hakim MS; Marcellus ; Trisnawati I; Khair RE; Triasih R; Irene ; Afiahayati ; Iskandar K; Siswanto ; Anggorowati N; Daniwijaya EW; Supriyati E; Nugrahaningsih DAA; Budiono E; Retnowulan H; Puspadewi Y; Puspitawati I; Sianipar O; Afandy D; Simanjaya S; Widitjiarso W; Puspitarani DA; Fahri F; Riawan U; Fauzi AR; Kalim AS; Ananda NR; Setyati A; Setyowireni D; Laksanawati IS; Arguni E; Nuryastuti T; Wibawa T;
    BMC Med Genomics; 2021 Jun; 14(1):144. PubMed ID: 34074255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes.
    Zekri AN; Mohanad M; Hafez MM; Soliman HK; Hassan ZK; Abouelhoda M; Amer KE; Seadawy MG; Ahmed OS
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166154. PubMed ID: 33932525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
    Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
    Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.
    Umair M; Ikram A; Salman M; Khurshid A; Alam M; Badar N; Suleman R; Tahir F; Sharif S; Montgomery J; Whitmer S; Klena J
    PLoS One; 2021; 16(3):e0248371. PubMed ID: 33755704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
    Soliman MS; AbdelFattah M; Aman SMN; Ibrahim LM; Aziz RK
    OMICS; 2021 Feb; 25(2):123-128. PubMed ID: 33253058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021.
    J Al-Awaida W; Jawabrah Al Hourani B; Swedan S; Nimer R; Alzoughool F; J Al-Ameer H; E Al Tamam S; Alashqar R; Al Bawareed O; Gushchina Y; Samy Abousenna M; Ayyash AM; Sharab A; M Alnaimat S; Imraish A; W Akash M; R Hadi N
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study.
    Novkovic M; Banovic Djeri B; Ristivojevic B; Knezevic A; Jankovic M; Tanasic V; Radojicic V; Keckarevic D; Vidanovic D; Tesovic B; Skakic A; Tolinacki M; Moric I; Djordjevic V
    Front Microbiol; 2024; 15():1332276. PubMed ID: 38476954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most accurate mutations in SARS-CoV-2 genomes identified in Uzbek patients show novel amino acid changes.
    Ayubov MS; Mirzakhmedov MK; Yusupov AN; Asrorov AM; Nosirov BV; Usmanov DE; Shermatov SE; Ubaydullaeva KA; Abdukarimov A; Buriev ZT; Abdurakhmonov IY
    Front Med (Lausanne); 2024; 11():1401655. PubMed ID: 38882660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021.
    Afrin SZ; Islam MT; Paul SK; Kobayashi N; Parvin R
    Virology; 2022 Jan; 565():29-37. PubMed ID: 34700068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.